19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
On January 1, some important changes to Massachusetts employment law took effect. Below are the high...
Read More >
New York’s statewide energy storage goal of 3,000 megawatts (MW) by 2030, with an interim objective...
Read More >
This October there are no tricks, but there are plenty of treats (assuming you have a sweet tooth fo...
Read More >
On January 1, 2020, a new Ohio Administrative Code Rule became effective with respect to payment for...
Read More >
Seyfarth Synopsis: Does Pennsylvania law permit the fluctuating workweek (“FWW”) method of paying ...
Read More >
With the worldwide cases of coronavirus tripling in the past week, and the eleventh case confirmed i...
Read More >